Skagen Global vs UBS Lux Equity Fund Biotech USD

Skagen Global vs UBS Lux Equity Fund Biotech USD

1. Skagen Global

  • Security

    Skagen Global A

  • Fee

    1.00%

  • ISIN

    NO0008004009

  • Holdings

    24

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

Fund Holdings

We have information about 25 holdings in Skagen Global, where the largest holding is Canadian Pacific Kansas City (6.94), followed by Microsoft (5.98) and TMX Group (5.74). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in Skagen Global and UBS Lux Equity Fund Biotech USD.

Skagen Global UBS Lux Equity Fund Biotech USD
1. Canadian Pacific Kansas City Ltd
Canada
6.94 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Microsoft Corp
USA
5.98 %
2. Moderna Inc
9.21 %
3. TMX Group Ltd
Canada
5.74 %
3. Gilead Sciences Inc
USA
4.66 %
4. Abbott Laboratories
USA
5.53 %
4. BioNTech SE
4.13 %
5. Amazon.com Inc
USA
5.35 %
5. Karuna Therapeutics Inc
3.75 %
6. Moody's Corp
USA
5.28 %
-
7. Waste Management Inc
USA
4.45 %
-
8. Aegon ADR
Netherlands
4.17 %
-
9. Mastercard Inc
USA
4.16 %
-
10. Muenchener Rueckversicherungs-Gesellschaft AG
Germany
4.15 %
-
11. MSCI Inc
USA
4.1 %
-
12. Visa Inc
USA
4.05 %
-
13. Alphabet Inc Class C
USA
3.79 %
-
14. RELX ADR
UK
3.78 %
-
15. Thomson Reuters Corp
Canada
3.73 %
-
16. Home Depot Inc
USA
3.21 %
-
17. Waste Connections Inc
Canada
2.95 %
-
18. Intercontinental Exchange Inc
USA
2.62 %
-
19. DSV Panalpina
Denmark
2.41 %
-
20. JP Morgan Chase & Co
USA
2.38 %
-
21. Samsung Electronics Co Ltd
South Korea
2.23 %
-
22. Hermes International SCA
France
2.2 %
-
23. Marsh & McLennan Companies Inc
USA
1.92 %
-
24. Mowi
Norway
1.28 %
-

The list of fund holdings was last updated on September 10, 2025.